5-112168813-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_022140.5(EPB41L4A):ā€‹c.1858A>Gā€‹(p.Thr620Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,613,122 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.000053 ( 0 hom., cov: 32)
Exomes š‘“: 0.000068 ( 0 hom. )

Consequence

EPB41L4A
NM_022140.5 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.91
Variant links:
Genes affected
EPB41L4A (HGNC:13278): (erythrocyte membrane protein band 4.1 like 4A) The protein encoded by this gene is a member of the band 4.1 protein superfamily. Members of this superfamily are thought to play an important role in regulating interactions between the cytoskeleton and plasma membrane, and contain an amino terminal conserved domain that binds glycophorin C. This gene product is thought to be involved in the beta-catenin signaling pathway. [provided by RefSeq, Dec 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11828667).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
EPB41L4ANM_022140.5 linkuse as main transcriptc.1858A>G p.Thr620Ala missense_variant 22/23 ENST00000261486.6 NP_071423.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
EPB41L4AENST00000261486.6 linkuse as main transcriptc.1858A>G p.Thr620Ala missense_variant 22/231 NM_022140.5 ENSP00000261486 P1
EPB41L4AENST00000507810.5 linkuse as main transcriptn.878A>G non_coding_transcript_exon_variant 11/142
EPB41L4AENST00000509342.6 linkuse as main transcriptn.306A>G non_coding_transcript_exon_variant 5/65

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152198
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000481
AC:
12
AN:
249486
Hom.:
0
AF XY:
0.0000296
AC XY:
4
AN XY:
135360
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000971
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.0000678
AC:
99
AN:
1460924
Hom.:
0
Cov.:
32
AF XY:
0.0000660
AC XY:
48
AN XY:
726798
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000855
Gnomad4 OTH exome
AF:
0.0000663
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152198
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000965
Hom.:
0
Bravo
AF:
0.0000831
ExAC
AF:
0.0000331
AC:
4
EpiCase
AF:
0.000327
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 06, 2022The c.1858A>G (p.T620A) alteration is located in exon 22 (coding exon 22) of the EPB41L4A gene. This alteration results from a A to G substitution at nucleotide position 1858, causing the threonine (T) at amino acid position 620 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0085
T;T
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.16
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.58
T;.
M_CAP
Benign
0.029
D
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-0.62
T
MutationAssessor
Benign
0.81
L;L
MutationTaster
Benign
0.71
N
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.40
.;N
REVEL
Benign
0.15
Sift
Benign
0.033
.;D
Sift4G
Benign
0.20
T;T
Polyphen
0.33
B;B
Vest4
0.17
MVP
0.82
MPC
0.042
ClinPred
0.098
T
GERP RS
4.4
Varity_R
0.082
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs761882734; hg19: chr5-111504510; API